MMED
MiniMed Group Inc. Common Stock
Healthcare · Medical Instruments & Supplies · NASDAQ · United States
$21.20+0.38%
Market cap $5.9BNext earnings 2026-09-01Updated Sep 22, 2026
FAIR VALUE · CONSENSUS
$21.20+0.0%
confidence-weighted across 2 of 6 models
Now $21.20
$21.20
$15.81$18.78
TrimSilver64
Price vs fair value
23.8% above
-19.2% to fair value
ACCE score
54
out of 100
P/E
0.0x
forward 0.0x
Dividend yield
0.00%
Unlock the ACCE read
INVESTOROverview
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
Price
+14.7% · 1Y
Valuation
INVESTORFull valuation engine INVESTOR FEATURE
Six independent models converge on one confidence-weighted fair value, with full methodology and editable assumptions.
- +All six models: DCF, P/E and EV/EBITDA comps, Graham, dividend discount, residual income
- +Scenario bands, sensitivity tornado, and the 5-year historical valuation range
- +Editable DCF workbench with saved scenarios
Quality
INVESTORQuality and conviction INVESTOR FEATURE
The full quality picture: conviction breakdown, earnings quality, score history, and backtested returns.
- +Conviction score breakdown and earnings-quality grade
- +Growth / value / quality / momentum component scores
- +90-day score history and score-threshold backtests
Analysts
Wall Street consensus
No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
- +Price-target low / average / high vs the current price, with implied upside
- +Forward revenue and EPS consensus by fiscal year
- +ACCE fair-value models lined up against the Street
Smart Money
PROSmart money tracking PRO FEATURE
Follow the institutions: 13F position changes, insider trades, and active 13D activist filings.
- +Quarter-over-quarter institutional position changes
- +Recent open-market insider transactions
- +Active 13D activist filings and top holders
Compare
Where it sits vs peers
This stock Peer Peer median weaker → stronger
P/Ebetter than 100% of peers
low 0.0x0.0xhigh 43.3x
ROEbetter than 0% of peers
low -9%-9%high 13%
Div yieldbetter than 50% of peers
low 0.0%0.0%high 3.5%
Algorithmic peers (6)
| Ticker | Company | Mcap | P/E | ROE | D/E | Yield | Quality | |
|---|---|---|---|---|---|---|---|---|
| BLCO | Bausch + Lomb Corporation Common Shares | $6.0B | - | -2.5% | 0.79 | 0.0% | - | Compare |
| STVN | Stevanato Group S.p.A. Ordinary Shares | $5.9B | 38.4 | 9.1% | 0.31 | 0.0% | - | Compare |
| CTEC.L | Convatec Group PLC | $5.6B | 43.3 | 7.6% | 0.95 | 3.5% | - | Compare |
| TFX | Teleflex Incorporated Common Stock | $5.3B | - | -0.7% | 0.85 | 1.1% | - | Compare |
| MMSI | Merit Medical Systems Inc. Common Stock | $5.1B | 35.2 | 9.2% | 0.47 | 0.0% | - | Compare |
| ATR | AptarGroup Inc. Common Stock | $7.8B | 22.3 | 13.5% | 0.56 | 1.5% | - | Compare |
Sector report card
Where MMED ranks against its sector peers on each metric.
Computing percentiles…
News and Record
Press releases mentioning this company
- PR Newswire•Sep 14, 2026Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc.
- PR Newswire•Sep 14, 2026MiniMed Files Form S-4 Registration Statement in Connection with Medtronic Exchange Offer Announcement
- PR Newswire•Aug 17, 2026MiniMed's Smallest App-Controlled Insulin Pump Now Shipping with the World's Smallest Sensor
4 more press releases · full archive on Investor+.INVESTOR
Ask anything, Pro feature
Ask questions about this stock in plain language. Answered from company fundamentals + recent valuations.
PRO
Recent performance
1 week
-3.7%
1 month
+3.7%
3 months
+50.0%
6 months
+38.8%
YTD
no data
1 year
no data
SEC filings
40 filings
September 2026
Sep 8
10-QQuarterly reportPeriod 2026-07-31
Sep 1
8-KCurrent reportPeriod 2026-09-01
August 2026
Aug 21
ProxyProxy statementPeriod 2026-10-09
37 more filings + AI summaries on Investor+.INVESTOR